{"ticker": {"uuid": "7ca183c2-9957-4846-8655-f8958ed06bec", "symbol": "NYXH", "name": "Nyxoah", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Instruments & Supplies"}, "articles": [{"title": "Price to sales forward of Nyxoah SA \u2013 SWB:5YI", "summary": "This article provides a brief financial overview for Nyxoah SA (SWB:5YI), focusing on its forward price-to-sales ratio. It indicates that no trades have occurred and presents links to various financial data, news, and community sections for the company on the TradingView platform", "url": "https://www.tradingview.com/symbols/SWB-5YI/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-11T01:40:34", "published_display": "11 Jul 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah Touts Genio U.S. Launch Traction, Reimbursement Stability at Investor Day", "summary": "", "url": "https://finance.yahoo.com/m/a704bae8-818a-36fb-80cb-9a15c1640a3b/nyxoah-touts-genio-u.s..html", "source_name": "MarketBeat", "published_at": "2026-07-10T23:02:20+00:00", "published_display": "10 Jul 2026 23:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah (NASDAQ: NYXH) posts Q2 2026 prelims, secures $110M and sees CMS propose higher Genio reimbursement", "summary": "Nyxoah (NASDAQ: NYXH) announced strong preliminary Q2 2026 results, with global net revenue expected to be \u20ac7.7 million and U.S. revenue \u20ac5.2 million, both demonstrating over 20% sequential growth. The company also secured $110 million in financing and anticipates a significant i", "url": "https://www.stocktitan.net/sec-filings/NYXH/6-k-nyxoah-sa-current-report-foreign-issuer-879dfa908641.html", "source_name": "Stock Titan", "published_at": "2026-07-09T20:11:17", "published_display": "09 Jul 2026 20:11", "sentiment": "positive", "sentiment_pct": 73, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stifel reiterates Hold on Nyxoah stock, keeps $3 price target", "summary": "Stifel has reiterated its Hold rating on Nyxoah SA stock, maintaining a $3.00 price target after the company's Investor Day. The firm expressed caution regarding Nyxoah's ambitious breakeven revenue and gross margin targets, noting that the company operates in a small market shar", "url": "https://www.investing.com/news/analyst-ratings/stifel-reiterates-hold-on-nyxoah-stock-keeps-3-price-target-93CH-4783922", "source_name": "Investing.com", "published_at": "2026-07-09T20:11:09", "published_display": "09 Jul 2026 20:11", "sentiment": "negative", "sentiment_pct": 37, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stifel reiterates Hold on Nyxoah stock, keeps $3 price target By Investing.com", "summary": "Stifel maintained its Hold rating and $3.00 price target for Nyxoah SA (NASDAQ:NYXH) following the company's Investor Day. The firm expressed a cautious outlook, citing limited new information, ambitious breakeven and gross margin targets, and the company's projected need for add", "url": "https://ng.investing.com/news/stock-market-news/stifel-reiterates-hold-on-nyxoah-stock-keeps-3-price-target-93CH-2593038", "source_name": "Investing.com Nigeria", "published_at": "2026-07-09T19:40:17", "published_display": "09 Jul 2026 19:40", "sentiment": "negative", "sentiment_pct": 36, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Baird Maintains Nyxoah SA(NYXH.US) With Hold Rating, Cuts Target Price to $2.85", "summary": "Baird has reiterated its Hold rating on Nyxoah SA (NYXH.US) but has reduced its target price for the company's shares to $2.85. This adjustment reflects Baird's updated outlook on Nyxoah SA's financial prospects and market valuation.", "url": "https://www.moomoo.com/news/post/72710733/baird-maintains-nyxoah-sa-nyxhus-with-hold-rating-cuts-target", "source_name": "Moomoo", "published_at": "2026-07-09T19:40:16", "published_display": "09 Jul 2026 19:40", "sentiment": "negative", "sentiment_pct": 31, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Nyxoah SA \u2013 SWB:5YI", "summary": "This article provides a brief financial overview of Nyxoah SA (SWB:5YI), focusing on its forward price-to-earnings ratio. The content indicates the market was closed with no trades at the time of viewing. It also lists various data providers for market and reference information.", "url": "https://www.tradingview.com/symbols/SWB-5YI/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-09T18:11:17", "published_display": "09 Jul 2026 18:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah Announces Preliminary Results for the Second Quarter of 2026", "summary": "Nyxoah announced preliminary unaudited second-quarter 2026 financial results, reporting an expected global net revenue of \u20ac7.7 million, driven by strong U.S. launch momentum. The company saw significant growth in U.S. net revenue and commercial indicators, including increased sur", "url": "https://www.globenewswire.com/news-release/2026/07/07/3323627/0/en/nyxoah-announces-preliminary-results-for-the-second-quarter-of-2026.html", "source_name": "GlobeNewswire", "published_at": "2026-07-08T19:40:16", "published_display": "08 Jul 2026 19:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah (ENXTBR:NYXH) Stock Fair Value Moves Lower After Capital Raise And Analyst Caution", "summary": "Nyxoah's analyst update has reduced its fair value estimate by approximately 21%, from \u20ac7.37 to \u20ac5.80, following a recent capital raise and analyst caution. While Piper Sandler remains optimistic about the Genio product's uptake and maintains an \"Overweight\" rating, Stifel has lo", "url": "https://finance.yahoo.com/markets/stocks/articles/nyxoah-enxtbr-nyxh-stock-fair-091502439.html", "source_name": "Market source", "published_at": "2026-07-08T09:11:09", "published_display": "08 Jul 2026 09:11", "sentiment": "negative", "sentiment_pct": 37, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah (NYXH) Reports Strong Momentum and Financial Progress in Q2", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywJBVV95cUxPaWZzVUN4SkVLMnJjWDlCSVJ1NDFlanJ0T2ZPSWlJbVEyWHppdUpPMzc0NHh3M1RVNEdYZkwtc2VJWll3Sll2cGcxcUlHYVFkb2tNOGxuYUd6cERMOHlkU0Q5UVNlR1IzeXQtMFY2bWVLbGJZeWMxXzctNm1PcFJmQTZlNFRuRnZjVV9vbldmR2t1THdBa0RNSjlXVFRPc0JSYmZXY0E0Zjh5XzB3bUd5SmhrbmQ0M3ZfRnc0WEJOQjVXc1gyTzdCUHhLOEdHcnVFdVd3S1BpdUM2NHVUTjhYQUsxby1JSWo5TVpid3JaQVY3RFVjWGJ5ZFZCdVpxdl8zYzVWdE9CQzA5cmNyTW82eVc3c2hNYjdBQ1RLY3Q4cC15NVYyaEFkWW9pU0YyX2FxMjVxa2laSDZLdmttMG1KVXhHaFd6M1JYWEZB?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-08T02:48:57+00:00", "published_display": "08 Jul 2026 02:48", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah reports Q2 2026 preliminary revenue of \u20ac7.7M", "summary": "Nyxoah reported preliminary revenue of \u20ac7.7 million for the second quarter of 2026. This financial update provides an early look at the company's performance during the last quarter.", "url": "https://www.msn.com/en-us/money/companies/nyxoah-reports-q2-2026-preliminary-revenue-of-7-7m/ar-AA27q7EB", "source_name": "MSN", "published_at": "2026-07-07T21:10:51", "published_display": "07 Jul 2026 21:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah Preliminary Q2 Revenue Rises From Q1; 2026 Outlook Reaffirmed", "summary": "Nyxoah reported preliminary second-quarter revenue of \u20ac1.7 million, an increase from \u20ac1.3 million in the first quarter of 2026, driven by growth in Germany. The company reaffirmed its 2026 outlook, expecting revenue between \u20ac9 million and \u20ac12 million and maintaining its gross mar", "url": "https://www.moomoo.com/news/post/72605450/nyxoah-preliminary-q2-revenue-rises-from-q1-2026-outlook-reaffirmed?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-07T21:10:51", "published_display": "07 Jul 2026 21:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah says U.S. launch lifted Q2 revenue 21% sequentially", "summary": "Nyxoah (Nasdaq:NYXH) announced preliminary, unaudited Q2 2026 results including global net revenue of \u20ac7.7 million, a 21% sequential increase, driven by U.S. revenue of \u20ac5.2 million, up 22%. The company reaffirmed its full-year 2026 revenue guidance of \u20ac36\u201340 million and detailed", "url": "https://www.stocktitan.net/news/NYXH/nyxoah-announces-preliminary-results-for-the-second-quarter-of-7z1829p8oman.html", "source_name": "Stock Titan", "published_at": "2026-07-07T20:10:50", "published_display": "07 Jul 2026 20:10", "sentiment": "positive", "sentiment_pct": 75, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NYXH - Nyxoah SA Latest SEC Filings", "summary": "This article provides the latest SEC filing information for Nyxoah SA (NYXH), including its current stock performance, key financial metrics, and various valuation ratios. The data covers market capitalization, sales, earnings per share (EPS) figures, insider and institutional ow", "url": "https://finviz.com/stock?t=NYXH&p=d&ty=lf", "source_name": "Finviz", "published_at": "2026-07-04T18:10:10", "published_display": "04 Jul 2026 18:10", "sentiment": "negative", "sentiment_pct": 39, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ResMed (NYSE: RMD) reports 1.95% stake in Nyxoah \u2014 1.94M shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQRDJaMU1uU284NGVWOVMzZDhpRW5xV09kVk5vWUN3NTRpdEZXdm9ESTUxZ1V3V1FUZWlYaW5MT2xNM3ZDTXBNc2xGRW1LN0tlVWhoRGJPZ1ZrcFJkWHpCaGpSQTFHOGplM0hsZlEzdTdWTE94ek1rX0xIbmJOUm9aNjVEbF9ydVduMVN6Uzh0YXl1cG9RZnk4ZEVTNFBRWHFaZUNPZzlfcWdfZDZhWWRjaUFZOHdYM0ZfaU9oX2hBYjkyQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah adds 146,531 shares as voting rights reach 100.1 million", "summary": "Nyxoah (Nasdaq: NYXH) has updated its share capital and voting rights as of June 30, 2026, following the issuance of 146,531 new shares from exercised restricted share units. The company's share capital is now EUR 7,075,152.31, with 100,072,815 ordinary shares and an equal number", "url": "https://www.stocktitan.net/news/NYXH/information-on-the-total-number-of-voting-rights-and-avgl5b31xi1s.html", "source_name": "Stock Titan", "published_at": "2026-07-01T04:10:28", "published_display": "01 Jul 2026 04:10", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Information on the total number of voting rights and shares", "summary": "Nyxoah SA has released updated information on its total number of voting rights and shares as of June 30, 2026. This follows the issuance of 146,531 new shares due to the exercise of restricted share units. The company reported a total of 100,072,815 voting rights and shares, alo", "url": "https://www.globenewswire.com/news-release/2026/06/30/3320146/0/en/information-on-the-total-number-of-voting-rights-and-shares.html", "source_name": "GlobeNewswire", "published_at": "2026-06-30T16:30:00", "published_display": "30 Jun 2026 16:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah sees Orin Hirchman cross 10% voting rights threshold, Resmed drops below 3%.", "summary": "Nyxoah SA announced that Orin Hirchman, through controlled entities, has acquired 14.55% of voting rights as of June 10, 2026, exceeding the 10% disclosure threshold. Concurrently, Resmed Inc. reduced its stake to 1.95%, falling below the 3% threshold. These shifts in significant", "url": "https://pluang.com/en/news-feed/notifikasi-transparansi-pemegang-saham-nyxoah", "source_name": "Pluang", "published_at": "2026-06-29T20:40:59", "published_display": "29 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah gets two ownership notices: AIGH at 14.55%, Resmed at 1.95%", "summary": "Nyxoah (NASDAQ: NYXH) has announced two significant transparency notifications concerning major shareholdings, dated June 10, 2026. Entities controlled by Orin Hirchman, through AIGH Investment Partners, LP and WVP Emerging Manager Onshore Fund LLC - AIGH Series, now collectively", "url": "https://www.stocktitan.net/news/NYXH/publication-relating-to-transparency-0pnt4v2863tk.html", "source_name": "Stock Titan", "published_at": "2026-06-29T20:40:58", "published_display": "29 Jun 2026 20:40", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Publication relating to transparency notifications", "summary": "Nyxoah SA announced that it received two transparency notifications regarding changes in shareholdings. Orin Hirchman's controlled entities acquired voting securities, crossing the 10% threshold to hold 14.55% of shares as of June 10, 2026. Separately, Resmed Inc. reported a pass", "url": "https://www.globenewswire.com/news-release/2026/06/29/3319310/0/en/publication-relating-to-transparency-notifications.html", "source_name": "GlobeNewswire", "published_at": "2026-06-29T20:40:58", "published_display": "29 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Nyxoah SA \u2013 LSX:A2QCWK", "summary": "This article presents financial information for Nyxoah SA (LSX:A2QCWK), specifically its forward price-to-earnings ratio. The content primarily consists of navigation and boilerplate text from TradingView, with a placeholder for the actual \"Period Value Change\" data. The financia", "url": "https://www.tradingview.com/symbols/LSX-A2QCWK/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T08:40:28", "published_display": "29 Jun 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NYXH Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for Nyxoah SA (NYXH) stock, gathering analysts' opinions on its future price, with a max estimate of 11.10 EUR and a min estimate of 2.58 EUR. It also details the company's recent financial performance, including earnings, revenue", "url": "https://www.tradingview.com/symbols/EURONEXT-NYXH/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T14:40:54", "published_display": "25 Jun 2026 14:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah to Host Investor Day in New York on July 8, 2026", "summary": "Nyxoah SA, a medical technology company specializing in Obstructive Sleep Apnea (OSA) solutions, announced it will host an Investor and Analyst Day in New York on Wednesday, July 8, 2026. The event will take place at Bank of America's offices from 10:00 AM to 12:30 PM ET and will", "url": "https://www.sahmcapital.com/news/content/nyxoah-to-host-investor-day-in-new-york-on-july-8-2026-2026-06-23", "source_name": "Sahm", "published_at": "2026-06-25T03:40:59", "published_display": "25 Jun 2026 03:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 6K Nyxoah For: 23 June By Investing.com", "summary": "This article announces the filing of Form 6K by Nyxoah on June 23, 2026. It appears to be a standard financial reporting notification from Investing.com, providing basic details without further commentary or analysis within the snippet provided.", "url": "https://ng.investing.com/news/stock-market-news/form-6k-nyxoah-for-23-june-93CH-2570757", "source_name": "Investing.com Nigeria", "published_at": "2026-06-24T13:39:58", "published_display": "24 Jun 2026 13:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah (ENXTBR:NYXH) Stock Fair Value Moves Lower After Analyst Cuts And Capital Concerns", "summary": "Nyxoah (ENXTBR:NYXH) has seen its fair value estimate drop by 18% to \u20ac7.37 per share, following analyst cuts influenced by concerns about capital needs and execution risk. While some analysts like Piper Sandler remain optimistic about the Genio launch and revenue trends, others l", "url": "https://finance.yahoo.com/markets/stocks/articles/nyxoah-enxtbr-nyxh-stock-fair-043059720.html", "source_name": "Market source", "published_at": "2026-06-24T12:30:00", "published_display": "24 Jun 2026 12:30", "sentiment": "negative", "sentiment_pct": 28, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah (NASDAQ: NYXH) adds $15M EIB debt and details major holders", "summary": "Nyxoah (NASDAQ: NYXH) has secured a $15 million loan tranche from the European Investment Bank, bringing its total new capital raised in June 2026 to approximately $110 million. This non-dilutive debt will fund the U.S. commercial launch of its Genio sleep apnea system, alongside", "url": "https://www.stocktitan.net/sec-filings/NYXH/6-k-nyxoah-sa-current-report-foreign-issuer-1d6c2ef00ff0.html", "source_name": "Stock Titan", "published_at": "2026-06-23T19:40:38", "published_display": "23 Jun 2026 19:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah lines up U.S. launch update, reimbursement talk for July 8", "summary": "Nyxoah (NYXH) will host an Investor and Analyst Day in New York on July 8, 2026, to discuss the U.S. Genio launch momentum, OSA market dynamics, reimbursement strategies, and the company\u2019s path to profitability. The event, held at Bank of America Tower, will feature Nyxoah's lead", "url": "https://www.stocktitan.net/news/NYXH/nyxoah-to-host-investor-day-in-new-york-on-july-8-owzkpi3bulw6.html", "source_name": "Stock Titan", "published_at": "2026-06-23T19:40:38", "published_display": "23 Jun 2026 19:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 13G NYXOAH SA For: 22 June By Investing.com", "summary": "This article reports on a Form 13G filing for NYXOAH SA on June 22. It is a brief announcement from Investing.com with no further details. The content primarily includes disclaimers about the risks of trading financial instruments and cryptocurrencies.", "url": "https://m.au.investing.com/news/stock-market-news/form-13g-nyxoah-sa-for-22-june-93CH-4497219?ampMode=1", "source_name": "Investing.com Australia", "published_at": "2026-06-22T16:39:18", "published_display": "22 Jun 2026 16:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AIGH entities and Orin Hirschman report 14.5% stake in NYXOAH (NASDAQ: NYXH)", "summary": "AIGH Capital Management LLC, AIGH Investment Partners LLC, and Orin Hirschman have jointly reported a 14.5% stake in NYXOAH (NASDAQ: NYXH), amounting to 14,534,880 shares of Common Stock. This Schedule 13G filing indicates that the reporting persons hold sole voting and dispositi", "url": "https://www.stocktitan.net/sec-filings/NYXH/schedule-13g-nyxoah-sa-passive-investment-disclosure-5-62022b3cb43a.html", "source_name": "Stock Titan", "published_at": "2026-06-22T10:12:42", "published_display": "22 Jun 2026 10:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah (NYXH) 44th Annual J.P. Morgan Healthcare Conference Summary", "summary": "Nyxoah (NYXH) presented at the 44th Annual J.P. Morgan Healthcare Conference, highlighting the significant market opportunity in obstructive sleep apnea (OSA) and the differentiating features of its Genio system. The company discussed its successful U.S. launch post-FDA approval,", "url": "https://quartr.com/events/nyxoah-nyxh-44th-annual-j-p-morgan-healthcare-conference_FLbtwlOY", "source_name": "Quartr", "published_at": "2026-06-21T12:12:42", "published_display": "21 Jun 2026 12:12", "sentiment": "positive", "sentiment_pct": 72, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stifel Maintains Nyxoah SA(NYXH.US) With Hold Rating, Maintains Target Price $3", "summary": "Stifel has reiterated its Hold rating for Nyxoah SA (NYXH.US) and maintained its target price at $3. This indicates that the firm sees the stock performing in line with the market, with no anticipated significant upward or downward movement from its current valuation.", "url": "https://www.moomoo.com/news/post/71799694/stifel-maintains-nyxoah-sa-nyxhus-with-hold-rating-maintains-target", "source_name": "Moomoo", "published_at": "2026-06-20T05:39:46", "published_display": "20 Jun 2026 05:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah seeks shareholder approval to renew capital authority July 9", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNOGM1UWhfU1JGQks3NWs4QjY2MVgxUjJFV3Ewb2RXcnpuem1XYnhHbjlidklvSkowcW9ueW1acExTOThxMHVEdG5vYzFVYWZrTV9Ya2NoU0VycEZlVGMzSE94MzBSWWJXQTVhbUdsdjRKZjRDeVFrSkw5cU1HOXRoS3RUQU42blR0Z2dpMUFHb0I3dHJ4YnQ0eVU5ekhwNUh1SkZ5RmdaNk5RaG9Wa3JRRnNMMjdaVEU1MURpY21n?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah Receives $15 Million From European Investment Bank", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/nyxoah-receives-15-million-european-203953456.html", "source_name": "MT Newswires", "published_at": "2026-06-17T20:39:53+00:00", "published_display": "17 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah taps another $15M as it readies Genio U.S. launch", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPT21zaWs0d1dhaDgwYzhmVFRBMHJYNjl1LWtoQjhBb0VEY2FfTkVaa2xQekZ1SWpZV3FsQjBweENpcmg1N05TUUk5TUVFb0VwV1NIU3lqWkJ6WGZPX3JqMHdYOVZ1ekVoQUpJUDR2VEtXT0ZZbXlad0cyT1FsUmFyeXFWNlVYbnR2WlBtSWdEQ0xacEVnLTJqSmc2YzdPQlJORGNQMGtDRldwWW9rMlBB?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah Stock Rebounds Nearly 7% After Bearish Rally", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPZ2FScmM2RVU2cFpQZG1DYlNlYW51LWhBSV9haWxSSS1SemhQcDZCOURrendnb0RlWGl6QjJXR2NXYnNCOG1HVmYxejZKdloyQzg4MVprWFZndnEwTk1tbDRFUzF6QWc2d2h5Z2Q5TmxySmxrV2RTZHR3S1MwaldDcXdXWl9GLTNNX2w0aElZMU45ZHAtSG1hZTU3clBDWnBPNmRrUzZDMktOeU8tNEE?oc=5", "source_name": "Id\u00e9al Investisseur", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah (NASDAQ: NYXH) adds 55,232,558 new shares after US offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNWmNuY1VIWWM4Ui1TMkFZNHFESWRld3Z0TEZ3UXVFeU0tWTZOSTkwTDRTdTRjUTNlUFdpQWtHS0NqclYzNXFydUlOcTRjczdtVHgyV0d1Tl80VWZ0TjB0djJFX1cxM1RGZE5uXzZ4WlpFUjdiS1J3Q3NBUlctbHU3SDRlMnVHUWRVMDlNRFRIN1Q1UVNqR3VpdWZ6SVhBX3NsWGI1VUdJMFo?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah raises $110 million to fund U.S. expansion of sleep apnea device", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQWHVFMmZHQVBqOTU3b1NHQlBSY2UxUWlkVEtmc1ZZUk1zcVFTWnRkRTRFSEUyLVMwanU5bjhsWHdPeHF1dFl0c2UyQ0xpQWk5THBaTXRCelI2Qm5zQ1cxOFBETHlNRzVqdXNoQ2VYQmFzc09oeGhoNWNwZHVBYl9fSnZ2NFpOUUYwblJIRjFDVlJaYmtMLUViOF9ldGw5T0xRMnVGdWRmaUlCRWtQV2JZbkUza0lBcjBLcTdLZzl3aURwdGs?oc=5", "source_name": "Investing.com", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah raises $95M to expand sleep apnea system in U.S., Europe", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQZEdBR09OMUE3b3EtemVRczFzR21uRFZkODk2TFZIZ2Y3XzdZUkZxUTFrbUw1bDdwcFRRMllDZHhad1Q1Z0Rqb1VTemFLOEdFdlQydFdadkZja3VkOVZkQldIYnJmOGFHc2lFTFdfX3FXazJHQ05UR2JHMVVZSTRzWi1xU3dyNjZJWjBkSmFtQlJiZEZ2N3F3S2JySHktU1hLaC1kcQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sleep apnea medtech Nyxoah lines up $110M for U.S. Genio push", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOUXFqZFlfU2YxeU5LcEF2TWpseHVhTzB3YzFGMDhjcm5wSE5fUlF6UVRwc2dSUFRFRy0tc0R1SDNKQ3NhekxxNUlvb1lXN2FiTzVCVzhtaHM1Y29oVjJIdnRIcGJ2b3VQcWlmTTRqVVpER0RaelNzVHNvbEJYVHFVMEpkTi1meGMtcVJOUWNhV1VEejNvZEhDRWNYUUJ0cTE2amg2V21vR1VnWGxZcTFmMDlOTV9fOVk?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah Launches Stock Offering to Fund Deployment of its Genio System", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNRmx1U2xiMGlWS1V1MlpTUnc3WHlZcUU5OVFONFZoNjVLU2xYOWNvdUNhVF81MGZVOWF4UWwxZ2NFUFJEb29YUEJQZWRCbjV1VXg5bHY2ZHQxWWVmN1NZMHExLXp0TFlXVVpaNXZaajN1UHctNzZJRFhDR21Cd1hrQ252TUhHREpvbjJqcDVVNU9XR0pfN1had2JuczRHN01oZmVUMjlnQUxSMUluNGQ4OHExaWo3VVhIaGFvSFhsNy1EZjdrWlVZ?oc=5", "source_name": "Id\u00e9al Investisseur", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah Initiates Succession of Olivier Taelman to Accelerate in the United States", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxPYnptZXd1T3EzcjVNY3hSVTdWZUp3SFB4S0ZiQm9EekRKWHFfWVZoTVRTWS1udzE2cmxxbjZZX25zZGowcy1LLW9jZGUyVDNkWTlpaUZIQ2FYaVdpYjE0WTg0T1AwX1o1S21PQVFLZDRTck94SFRzdjE5ek81aVMzNW5vdG9KT1JuYzJjaDF1YkpkNEdtRWhTeVZjdGd4aXBpd0dGVzR3OXFrVklWRjFSc3VNdVVyRWtYZ0htT3BlZ3M2enFMb1ptX2otMEpMMU1NbnhvWHExMA?oc=5", "source_name": "Id\u00e9al Investisseur", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah seeks cash to expand U.S. sleep apnea treatment push", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQbVFhQl9pa1M0YVNOLUZmUFFOWjhFc2Z6dU8tVG9fTGVkR3BJb0U5ZXBPYkhSSkFGMUdicUQ3bzFpdzludF9MZkNEZlVxd0NuSXFjSWJxcUR0dmJ6OU8zQmVwTGJTZk95TEJhc0VMRGwxNGYwbHdjbVVva3pTaVd6MVNBSTlsb2NndlJUb1ZXU3dqcFNqc3k1S2NSeE5wMGFuS0pF?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah Showcases Commercial Progress of Genio System in the United States", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNSXZvSjhseUJlUU1kN0d4eWdUVWZmc0RfaDZOd0xQTlRCU1JtWGpjb0dJMVQwYm52THpwRmF5V1ZGcGlVQ0ZIaDdUcXhQSmJLV05UbVRkYk40aFpQMlFZWExDeElGdjJtdk9jbHVQUGZGcDh3UnpOa3ZXLW9ic3I4Q0NxWklLaUhjQllOaHpjNkhuR1Y5em93MXJkVVJhUGpyYXl3NUNSMjFrMHlCenlTbGpOMUlVY196THZtc1NIYm4xdTlsNDJnLVRwRE0?oc=5", "source_name": "Id\u00e9al Investisseur", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah Q1 Earnings Call Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNVEdad3FTOG1tWG5XcTZJR09fS0htZkp3anR1SHVQMzJRWDRXMmJVUzNDV0d5aGN2enprNENXYnRZdkI3cFVDMnF3bGpITnBXSzNNYmZHWllPbzVQeVhqYkFITHBSYm12RXBOaV9HaWZhamRfbVUtaTlvU2c4UDJVMmNzc19mNmFDNGs3Wjg5QWs0OWhVWFZnbHJrQQ?oc=5", "source_name": "TradingView", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah SA (NYXH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOOWJ5NEFKS3o0ZzR2TC1MU2RpSDBDbnBzd3N1UV9sRjV0SnVKaVBjNlExUU5EeEUwNUZWRkcwZXNGSmpmRktxM3J5b0dBb21xeVhSR2g0bEdtU2U2UmR6MDhjWEQ1MmV5QllqVHVqNjhqczVWRHB6bDZ1dzlCZlRVQ1BhWkRqQmYzWk8xYklDUjM0SjRN?oc=5", "source_name": "Market source", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah SA (NYXH) Reports Q4 Loss, Misses Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPcENvTjhHOUwxWEkxN3RnaC1SRWJKbl8zcVVSSnhZSmRDVTN2RzdSc2M0X0IxdVU4ZUVzQ2xIcHNBMzhQa3JUNEt0ZEkzSHVseGpFdTRQNHpnNmNRU3ZkRmNmRGxoTU1ad2o0MHpZdnJwUHFRT0Zyd3pKa0F4VWRmalNva3dpVnJxTGVnUXVXVTFMNmxK?oc=5", "source_name": "Market source", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah Shares Rise on First U.S. Commercial Use of Genio System", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTFBvTGliVENUZXpqSTBqSUtkLW1Cc1lVNWZMMWctdUhNQ1FDZzEzalhjb0QtY1p2TnNsZE1Hblh4ZVB5VzNESjZsalFnZk5KNktaRXJWMlBKcGRJZWRTNFlnRnZtWWJvb3g0THNra2o1c3c2S0VFUVFWdk9zWEc?oc=5", "source_name": "Market source", "published_at": "2025-10-07T07:00:00+00:00", "published_display": "07 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah gets FDA clearance for sleep apnea device Genio", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQczV4QmdHZHdQV2w0cVdQRFVCeG1QYzBidDM3YVZoak5jZ29abTR0Y19ObF9yYUEwbnZEVkQ4aHBET2U3Q2E4ZThEdk1XbW5yNVRVdElURkRpdjFGMGpLSmVydy1hLWNkam5XZXVPT0VwaVZacnBJV2N5MUtxN0lTUnlWZ050RExoSm5TUlltMA?oc=5", "source_name": "MobiHealthNews", "published_at": "2025-08-12T07:00:00+00:00", "published_display": "12 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NYXOAH S A (NYXH) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE5xT3BjbjYtTThOSzhiNjE2aS1TWk1FNE5fZmFjay1oLWt3bnBQMFMzaU1QUTlKLU1fUHNXZE5lMVN6bzI2OTZFek5Kb2MxQQ?oc=5", "source_name": "Stock Titan", "published_at": "2021-06-29T17:02:00+00:00", "published_display": "29 Jun 2021 17:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Price to sales forward of Nyxoah SA \u2013 SWB:5YI", "summary": "This article provides a brief financial overview for Nyxoah SA (SWB:5YI), focusing on its forward price-to-sales ratio. It indicates that no trades have occurred and presents links to various financial data, news, and community sections for the company on the TradingView platform", "url": "https://www.tradingview.com/symbols/SWB-5YI/financials-statistics-and-ratios/price-sales-fwd/", "source_name": "TradingView", "published_at": "2026-07-11T01:40:34", "published_display": "11 Jul 2026 01:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah Touts Genio U.S. Launch Traction, Reimbursement Stability at Investor Day", "summary": "", "url": "https://finance.yahoo.com/m/a704bae8-818a-36fb-80cb-9a15c1640a3b/nyxoah-touts-genio-u.s..html", "source_name": "MarketBeat", "published_at": "2026-07-10T23:02:20+00:00", "published_display": "10 Jul 2026 23:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah (NASDAQ: NYXH) posts Q2 2026 prelims, secures $110M and sees CMS propose higher Genio reimbursement", "summary": "Nyxoah (NASDAQ: NYXH) announced strong preliminary Q2 2026 results, with global net revenue expected to be \u20ac7.7 million and U.S. revenue \u20ac5.2 million, both demonstrating over 20% sequential growth. The company also secured $110 million in financing and anticipates a significant i", "url": "https://www.stocktitan.net/sec-filings/NYXH/6-k-nyxoah-sa-current-report-foreign-issuer-879dfa908641.html", "source_name": "Stock Titan", "published_at": "2026-07-09T20:11:17", "published_display": "09 Jul 2026 20:11", "sentiment": "positive", "sentiment_pct": 73, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stifel reiterates Hold on Nyxoah stock, keeps $3 price target", "summary": "Stifel has reiterated its Hold rating on Nyxoah SA stock, maintaining a $3.00 price target after the company's Investor Day. The firm expressed caution regarding Nyxoah's ambitious breakeven revenue and gross margin targets, noting that the company operates in a small market shar", "url": "https://www.investing.com/news/analyst-ratings/stifel-reiterates-hold-on-nyxoah-stock-keeps-3-price-target-93CH-4783922", "source_name": "Investing.com", "published_at": "2026-07-09T20:11:09", "published_display": "09 Jul 2026 20:11", "sentiment": "negative", "sentiment_pct": 37, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stifel reiterates Hold on Nyxoah stock, keeps $3 price target By Investing.com", "summary": "Stifel maintained its Hold rating and $3.00 price target for Nyxoah SA (NASDAQ:NYXH) following the company's Investor Day. The firm expressed a cautious outlook, citing limited new information, ambitious breakeven and gross margin targets, and the company's projected need for add", "url": "https://ng.investing.com/news/stock-market-news/stifel-reiterates-hold-on-nyxoah-stock-keeps-3-price-target-93CH-2593038", "source_name": "Investing.com Nigeria", "published_at": "2026-07-09T19:40:17", "published_display": "09 Jul 2026 19:40", "sentiment": "negative", "sentiment_pct": 36, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Baird Maintains Nyxoah SA(NYXH.US) With Hold Rating, Cuts Target Price to $2.85", "summary": "Baird has reiterated its Hold rating on Nyxoah SA (NYXH.US) but has reduced its target price for the company's shares to $2.85. This adjustment reflects Baird's updated outlook on Nyxoah SA's financial prospects and market valuation.", "url": "https://www.moomoo.com/news/post/72710733/baird-maintains-nyxoah-sa-nyxhus-with-hold-rating-cuts-target", "source_name": "Moomoo", "published_at": "2026-07-09T19:40:16", "published_display": "09 Jul 2026 19:40", "sentiment": "negative", "sentiment_pct": 31, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Nyxoah SA \u2013 SWB:5YI", "summary": "This article provides a brief financial overview of Nyxoah SA (SWB:5YI), focusing on its forward price-to-earnings ratio. The content indicates the market was closed with no trades at the time of viewing. It also lists various data providers for market and reference information.", "url": "https://www.tradingview.com/symbols/SWB-5YI/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-09T18:11:17", "published_display": "09 Jul 2026 18:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah Announces Preliminary Results for the Second Quarter of 2026", "summary": "Nyxoah announced preliminary unaudited second-quarter 2026 financial results, reporting an expected global net revenue of \u20ac7.7 million, driven by strong U.S. launch momentum. The company saw significant growth in U.S. net revenue and commercial indicators, including increased sur", "url": "https://www.globenewswire.com/news-release/2026/07/07/3323627/0/en/nyxoah-announces-preliminary-results-for-the-second-quarter-of-2026.html", "source_name": "GlobeNewswire", "published_at": "2026-07-08T19:40:16", "published_display": "08 Jul 2026 19:40", "sentiment": "positive", "sentiment_pct": 73, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah (ENXTBR:NYXH) Stock Fair Value Moves Lower After Capital Raise And Analyst Caution", "summary": "Nyxoah's analyst update has reduced its fair value estimate by approximately 21%, from \u20ac7.37 to \u20ac5.80, following a recent capital raise and analyst caution. While Piper Sandler remains optimistic about the Genio product's uptake and maintains an \"Overweight\" rating, Stifel has lo", "url": "https://finance.yahoo.com/markets/stocks/articles/nyxoah-enxtbr-nyxh-stock-fair-091502439.html", "source_name": "Market source", "published_at": "2026-07-08T09:11:09", "published_display": "08 Jul 2026 09:11", "sentiment": "negative", "sentiment_pct": 37, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah (NYXH) Reports Strong Momentum and Financial Progress in Q2", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywJBVV95cUxPaWZzVUN4SkVLMnJjWDlCSVJ1NDFlanJ0T2ZPSWlJbVEyWHppdUpPMzc0NHh3M1RVNEdYZkwtc2VJWll3Sll2cGcxcUlHYVFkb2tNOGxuYUd6cERMOHlkU0Q5UVNlR1IzeXQtMFY2bWVLbGJZeWMxXzctNm1PcFJmQTZlNFRuRnZjVV9vbldmR2t1THdBa0RNSjlXVFRPc0JSYmZXY0E0Zjh5XzB3bUd5SmhrbmQ0M3ZfRnc0WEJOQjVXc1gyTzdCUHhLOEdHcnVFdVd3S1BpdUM2NHVUTjhYQUsxby1JSWo5TVpid3JaQVY3RFVjWGJ5ZFZCdVpxdl8zYzVWdE9CQzA5cmNyTW82eVc3c2hNYjdBQ1RLY3Q4cC15NVYyaEFkWW9pU0YyX2FxMjVxa2laSDZLdmttMG1KVXhHaFd6M1JYWEZB?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-08T02:48:57+00:00", "published_display": "08 Jul 2026 02:48", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah reports Q2 2026 preliminary revenue of \u20ac7.7M", "summary": "Nyxoah reported preliminary revenue of \u20ac7.7 million for the second quarter of 2026. This financial update provides an early look at the company's performance during the last quarter.", "url": "https://www.msn.com/en-us/money/companies/nyxoah-reports-q2-2026-preliminary-revenue-of-7-7m/ar-AA27q7EB", "source_name": "MSN", "published_at": "2026-07-07T21:10:51", "published_display": "07 Jul 2026 21:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah Preliminary Q2 Revenue Rises From Q1; 2026 Outlook Reaffirmed", "summary": "Nyxoah reported preliminary second-quarter revenue of \u20ac1.7 million, an increase from \u20ac1.3 million in the first quarter of 2026, driven by growth in Germany. The company reaffirmed its 2026 outlook, expecting revenue between \u20ac9 million and \u20ac12 million and maintaining its gross mar", "url": "https://www.moomoo.com/news/post/72605450/nyxoah-preliminary-q2-revenue-rises-from-q1-2026-outlook-reaffirmed?futusource=news_newspage_recommend", "source_name": "Moomoo", "published_at": "2026-07-07T21:10:51", "published_display": "07 Jul 2026 21:10", "sentiment": "positive", "sentiment_pct": 72, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah says U.S. launch lifted Q2 revenue 21% sequentially", "summary": "Nyxoah (Nasdaq:NYXH) announced preliminary, unaudited Q2 2026 results including global net revenue of \u20ac7.7 million, a 21% sequential increase, driven by U.S. revenue of \u20ac5.2 million, up 22%. The company reaffirmed its full-year 2026 revenue guidance of \u20ac36\u201340 million and detailed", "url": "https://www.stocktitan.net/news/NYXH/nyxoah-announces-preliminary-results-for-the-second-quarter-of-7z1829p8oman.html", "source_name": "Stock Titan", "published_at": "2026-07-07T20:10:50", "published_display": "07 Jul 2026 20:10", "sentiment": "positive", "sentiment_pct": 75, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NYXH - Nyxoah SA Latest SEC Filings", "summary": "This article provides the latest SEC filing information for Nyxoah SA (NYXH), including its current stock performance, key financial metrics, and various valuation ratios. The data covers market capitalization, sales, earnings per share (EPS) figures, insider and institutional ow", "url": "https://finviz.com/stock?t=NYXH&p=d&ty=lf", "source_name": "Finviz", "published_at": "2026-07-04T18:10:10", "published_display": "04 Jul 2026 18:10", "sentiment": "negative", "sentiment_pct": 39, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ResMed (NYSE: RMD) reports 1.95% stake in Nyxoah \u2014 1.94M shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQRDJaMU1uU284NGVWOVMzZDhpRW5xV09kVk5vWUN3NTRpdEZXdm9ESTUxZ1V3V1FUZWlYaW5MT2xNM3ZDTXBNc2xGRW1LN0tlVWhoRGJPZ1ZrcFJkWHpCaGpSQTFHOGplM0hsZlEzdTdWTE94ek1rX0xIbmJOUm9aNjVEbF9ydVduMVN6Uzh0YXl1cG9RZnk4ZEVTNFBRWHFaZUNPZzlfcWdfZDZhWWRjaUFZOHdYM0ZfaU9oX2hBYjkyQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-01T07:00:00+00:00", "published_display": "01 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah adds 146,531 shares as voting rights reach 100.1 million", "summary": "Nyxoah (Nasdaq: NYXH) has updated its share capital and voting rights as of June 30, 2026, following the issuance of 146,531 new shares from exercised restricted share units. The company's share capital is now EUR 7,075,152.31, with 100,072,815 ordinary shares and an equal number", "url": "https://www.stocktitan.net/news/NYXH/information-on-the-total-number-of-voting-rights-and-avgl5b31xi1s.html", "source_name": "Stock Titan", "published_at": "2026-07-01T04:10:28", "published_display": "01 Jul 2026 04:10", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Information on the total number of voting rights and shares", "summary": "Nyxoah SA has released updated information on its total number of voting rights and shares as of June 30, 2026. This follows the issuance of 146,531 new shares due to the exercise of restricted share units. The company reported a total of 100,072,815 voting rights and shares, alo", "url": "https://www.globenewswire.com/news-release/2026/06/30/3320146/0/en/information-on-the-total-number-of-voting-rights-and-shares.html", "source_name": "GlobeNewswire", "published_at": "2026-06-30T16:30:00", "published_display": "30 Jun 2026 16:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah sees Orin Hirchman cross 10% voting rights threshold, Resmed drops below 3%.", "summary": "Nyxoah SA announced that Orin Hirchman, through controlled entities, has acquired 14.55% of voting rights as of June 10, 2026, exceeding the 10% disclosure threshold. Concurrently, Resmed Inc. reduced its stake to 1.95%, falling below the 3% threshold. These shifts in significant", "url": "https://pluang.com/en/news-feed/notifikasi-transparansi-pemegang-saham-nyxoah", "source_name": "Pluang", "published_at": "2026-06-29T20:40:59", "published_display": "29 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah gets two ownership notices: AIGH at 14.55%, Resmed at 1.95%", "summary": "Nyxoah (NASDAQ: NYXH) has announced two significant transparency notifications concerning major shareholdings, dated June 10, 2026. Entities controlled by Orin Hirchman, through AIGH Investment Partners, LP and WVP Emerging Manager Onshore Fund LLC - AIGH Series, now collectively", "url": "https://www.stocktitan.net/news/NYXH/publication-relating-to-transparency-0pnt4v2863tk.html", "source_name": "Stock Titan", "published_at": "2026-06-29T20:40:58", "published_display": "29 Jun 2026 20:40", "sentiment": "positive", "sentiment_pct": 61, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Publication relating to transparency notifications", "summary": "Nyxoah SA announced that it received two transparency notifications regarding changes in shareholdings. Orin Hirchman's controlled entities acquired voting securities, crossing the 10% threshold to hold 14.55% of shares as of June 10, 2026. Separately, Resmed Inc. reported a pass", "url": "https://www.globenewswire.com/news-release/2026/06/29/3319310/0/en/publication-relating-to-transparency-notifications.html", "source_name": "GlobeNewswire", "published_at": "2026-06-29T20:40:58", "published_display": "29 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Nyxoah SA \u2013 LSX:A2QCWK", "summary": "This article presents financial information for Nyxoah SA (LSX:A2QCWK), specifically its forward price-to-earnings ratio. The content primarily consists of navigation and boilerplate text from TradingView, with a placeholder for the actual \"Period Value Change\" data. The financia", "url": "https://www.tradingview.com/symbols/LSX-A2QCWK/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-06-29T08:40:28", "published_display": "29 Jun 2026 08:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NYXH Forecast \u2014 Price Target \u2014 Prediction for 2027", "summary": "This article provides a forecast and price target for Nyxoah SA (NYXH) stock, gathering analysts' opinions on its future price, with a max estimate of 11.10 EUR and a min estimate of 2.58 EUR. It also details the company's recent financial performance, including earnings, revenue", "url": "https://www.tradingview.com/symbols/EURONEXT-NYXH/forecast-price-target/", "source_name": "TradingView", "published_at": "2026-06-25T14:40:54", "published_display": "25 Jun 2026 14:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah to Host Investor Day in New York on July 8, 2026", "summary": "Nyxoah SA, a medical technology company specializing in Obstructive Sleep Apnea (OSA) solutions, announced it will host an Investor and Analyst Day in New York on Wednesday, July 8, 2026. The event will take place at Bank of America's offices from 10:00 AM to 12:30 PM ET and will", "url": "https://www.sahmcapital.com/news/content/nyxoah-to-host-investor-day-in-new-york-on-july-8-2026-2026-06-23", "source_name": "Sahm", "published_at": "2026-06-25T03:40:59", "published_display": "25 Jun 2026 03:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 6K Nyxoah For: 23 June By Investing.com", "summary": "This article announces the filing of Form 6K by Nyxoah on June 23, 2026. It appears to be a standard financial reporting notification from Investing.com, providing basic details without further commentary or analysis within the snippet provided.", "url": "https://ng.investing.com/news/stock-market-news/form-6k-nyxoah-for-23-june-93CH-2570757", "source_name": "Investing.com Nigeria", "published_at": "2026-06-24T13:39:58", "published_display": "24 Jun 2026 13:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah (ENXTBR:NYXH) Stock Fair Value Moves Lower After Analyst Cuts And Capital Concerns", "summary": "Nyxoah (ENXTBR:NYXH) has seen its fair value estimate drop by 18% to \u20ac7.37 per share, following analyst cuts influenced by concerns about capital needs and execution risk. While some analysts like Piper Sandler remain optimistic about the Genio launch and revenue trends, others l", "url": "https://finance.yahoo.com/markets/stocks/articles/nyxoah-enxtbr-nyxh-stock-fair-043059720.html", "source_name": "Market source", "published_at": "2026-06-24T12:30:00", "published_display": "24 Jun 2026 12:30", "sentiment": "negative", "sentiment_pct": 28, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah (NASDAQ: NYXH) adds $15M EIB debt and details major holders", "summary": "Nyxoah (NASDAQ: NYXH) has secured a $15 million loan tranche from the European Investment Bank, bringing its total new capital raised in June 2026 to approximately $110 million. This non-dilutive debt will fund the U.S. commercial launch of its Genio sleep apnea system, alongside", "url": "https://www.stocktitan.net/sec-filings/NYXH/6-k-nyxoah-sa-current-report-foreign-issuer-1d6c2ef00ff0.html", "source_name": "Stock Titan", "published_at": "2026-06-23T19:40:38", "published_display": "23 Jun 2026 19:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah lines up U.S. launch update, reimbursement talk for July 8", "summary": "Nyxoah (NYXH) will host an Investor and Analyst Day in New York on July 8, 2026, to discuss the U.S. Genio launch momentum, OSA market dynamics, reimbursement strategies, and the company\u2019s path to profitability. The event, held at Bank of America Tower, will feature Nyxoah's lead", "url": "https://www.stocktitan.net/news/NYXH/nyxoah-to-host-investor-day-in-new-york-on-july-8-owzkpi3bulw6.html", "source_name": "Stock Titan", "published_at": "2026-06-23T19:40:38", "published_display": "23 Jun 2026 19:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 13G NYXOAH SA For: 22 June By Investing.com", "summary": "This article reports on a Form 13G filing for NYXOAH SA on June 22. It is a brief announcement from Investing.com with no further details. The content primarily includes disclaimers about the risks of trading financial instruments and cryptocurrencies.", "url": "https://m.au.investing.com/news/stock-market-news/form-13g-nyxoah-sa-for-22-june-93CH-4497219?ampMode=1", "source_name": "Investing.com Australia", "published_at": "2026-06-22T16:39:18", "published_display": "22 Jun 2026 16:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "AIGH entities and Orin Hirschman report 14.5% stake in NYXOAH (NASDAQ: NYXH)", "summary": "AIGH Capital Management LLC, AIGH Investment Partners LLC, and Orin Hirschman have jointly reported a 14.5% stake in NYXOAH (NASDAQ: NYXH), amounting to 14,534,880 shares of Common Stock. This Schedule 13G filing indicates that the reporting persons hold sole voting and dispositi", "url": "https://www.stocktitan.net/sec-filings/NYXH/schedule-13g-nyxoah-sa-passive-investment-disclosure-5-62022b3cb43a.html", "source_name": "Stock Titan", "published_at": "2026-06-22T10:12:42", "published_display": "22 Jun 2026 10:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah (NYXH) 44th Annual J.P. Morgan Healthcare Conference Summary", "summary": "Nyxoah (NYXH) presented at the 44th Annual J.P. Morgan Healthcare Conference, highlighting the significant market opportunity in obstructive sleep apnea (OSA) and the differentiating features of its Genio system. The company discussed its successful U.S. launch post-FDA approval,", "url": "https://quartr.com/events/nyxoah-nyxh-44th-annual-j-p-morgan-healthcare-conference_FLbtwlOY", "source_name": "Quartr", "published_at": "2026-06-21T12:12:42", "published_display": "21 Jun 2026 12:12", "sentiment": "positive", "sentiment_pct": 72, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Stifel Maintains Nyxoah SA(NYXH.US) With Hold Rating, Maintains Target Price $3", "summary": "Stifel has reiterated its Hold rating for Nyxoah SA (NYXH.US) and maintained its target price at $3. This indicates that the firm sees the stock performing in line with the market, with no anticipated significant upward or downward movement from its current valuation.", "url": "https://www.moomoo.com/news/post/71799694/stifel-maintains-nyxoah-sa-nyxhus-with-hold-rating-maintains-target", "source_name": "Moomoo", "published_at": "2026-06-20T05:39:46", "published_display": "20 Jun 2026 05:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah seeks shareholder approval to renew capital authority July 9", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNOGM1UWhfU1JGQks3NWs4QjY2MVgxUjJFV3Ewb2RXcnpuem1XYnhHbjlidklvSkowcW9ueW1acExTOThxMHVEdG5vYzFVYWZrTV9Ya2NoU0VycEZlVGMzSE94MzBSWWJXQTVhbUdsdjRKZjRDeVFrSkw5cU1HOXRoS3RUQU42blR0Z2dpMUFHb0I3dHJ4YnQ0eVU5ekhwNUh1SkZ5RmdaNk5RaG9Wa3JRRnNMMjdaVEU1MURpY21n?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-19T07:00:00+00:00", "published_display": "19 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah Receives $15 Million From European Investment Bank", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/nyxoah-receives-15-million-european-203953456.html", "source_name": "MT Newswires", "published_at": "2026-06-17T20:39:53+00:00", "published_display": "17 Jun 2026 20:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah taps another $15M as it readies Genio U.S. launch", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPT21zaWs0d1dhaDgwYzhmVFRBMHJYNjl1LWtoQjhBb0VEY2FfTkVaa2xQekZ1SWpZV3FsQjBweENpcmg1N05TUUk5TUVFb0VwV1NIU3lqWkJ6WGZPX3JqMHdYOVZ1ekVoQUpJUDR2VEtXT0ZZbXlad0cyT1FsUmFyeXFWNlVYbnR2WlBtSWdEQ0xacEVnLTJqSmc2YzdPQlJORGNQMGtDRldwWW9rMlBB?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah Stock Rebounds Nearly 7% After Bearish Rally", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPZ2FScmM2RVU2cFpQZG1DYlNlYW51LWhBSV9haWxSSS1SemhQcDZCOURrendnb0RlWGl6QjJXR2NXYnNCOG1HVmYxejZKdloyQzg4MVprWFZndnEwTk1tbDRFUzF6QWc2d2h5Z2Q5TmxySmxrV2RTZHR3S1MwaldDcXdXWl9GLTNNX2w0aElZMU45ZHAtSG1hZTU3clBDWnBPNmRrUzZDMktOeU8tNEE?oc=5", "source_name": "Id\u00e9al Investisseur", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah (NASDAQ: NYXH) adds 55,232,558 new shares after US offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNWmNuY1VIWWM4Ui1TMkFZNHFESWRld3Z0TEZ3UXVFeU0tWTZOSTkwTDRTdTRjUTNlUFdpQWtHS0NqclYzNXFydUlOcTRjczdtVHgyV0d1Tl80VWZ0TjB0djJFX1cxM1RGZE5uXzZ4WlpFUjdiS1J3Q3NBUlctbHU3SDRlMnVHUWRVMDlNRFRIN1Q1UVNqR3VpdWZ6SVhBX3NsWGI1VUdJMFo?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah raises $110 million to fund U.S. expansion of sleep apnea device", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxQWHVFMmZHQVBqOTU3b1NHQlBSY2UxUWlkVEtmc1ZZUk1zcVFTWnRkRTRFSEUyLVMwanU5bjhsWHdPeHF1dFl0c2UyQ0xpQWk5THBaTXRCelI2Qm5zQ1cxOFBETHlNRzVqdXNoQ2VYQmFzc09oeGhoNWNwZHVBYl9fSnZ2NFpOUUYwblJIRjFDVlJaYmtMLUViOF9ldGw5T0xRMnVGdWRmaUlCRWtQV2JZbkUza0lBcjBLcTdLZzl3aURwdGs?oc=5", "source_name": "Investing.com", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah raises $95M to expand sleep apnea system in U.S., Europe", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxQZEdBR09OMUE3b3EtemVRczFzR21uRFZkODk2TFZIZ2Y3XzdZUkZxUTFrbUw1bDdwcFRRMllDZHhad1Q1Z0Rqb1VTemFLOEdFdlQydFdadkZja3VkOVZkQldIYnJmOGFHc2lFTFdfX3FXazJHQ05UR2JHMVVZSTRzWi1xU3dyNjZJWjBkSmFtQlJiZEZ2N3F3S2JySHktU1hLaC1kcQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Sleep apnea medtech Nyxoah lines up $110M for U.S. Genio push", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxOUXFqZFlfU2YxeU5LcEF2TWpseHVhTzB3YzFGMDhjcm5wSE5fUlF6UVRwc2dSUFRFRy0tc0R1SDNKQ3NhekxxNUlvb1lXN2FiTzVCVzhtaHM1Y29oVjJIdnRIcGJ2b3VQcWlmTTRqVVpER0RaelNzVHNvbEJYVHFVMEpkTi1meGMtcVJOUWNhV1VEejNvZEhDRWNYUUJ0cTE2amg2V21vR1VnWGxZcTFmMDlOTV9fOVk?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-10T07:00:00+00:00", "published_display": "10 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah Launches Stock Offering to Fund Deployment of its Genio System", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxNRmx1U2xiMGlWS1V1MlpTUnc3WHlZcUU5OVFONFZoNjVLU2xYOWNvdUNhVF81MGZVOWF4UWwxZ2NFUFJEb29YUEJQZWRCbjV1VXg5bHY2ZHQxWWVmN1NZMHExLXp0TFlXVVpaNXZaajN1UHctNzZJRFhDR21Cd1hrQ252TUhHREpvbjJqcDVVNU9XR0pfN1had2JuczRHN01oZmVUMjlnQUxSMUluNGQ4OHExaWo3VVhIaGFvSFhsNy1EZjdrWlVZ?oc=5", "source_name": "Id\u00e9al Investisseur", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah Initiates Succession of Olivier Taelman to Accelerate in the United States", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxPYnptZXd1T3EzcjVNY3hSVTdWZUp3SFB4S0ZiQm9EekRKWHFfWVZoTVRTWS1udzE2cmxxbjZZX25zZGowcy1LLW9jZGUyVDNkWTlpaUZIQ2FYaVdpYjE0WTg0T1AwX1o1S21PQVFLZDRTck94SFRzdjE5ek81aVMzNW5vdG9KT1JuYzJjaDF1YkpkNEdtRWhTeVZjdGd4aXBpd0dGVzR3OXFrVklWRjFSc3VNdVVyRWtYZ0htT3BlZ3M2enFMb1ptX2otMEpMMU1NbnhvWHExMA?oc=5", "source_name": "Id\u00e9al Investisseur", "published_at": "2026-06-05T07:00:00+00:00", "published_display": "05 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah seeks cash to expand U.S. sleep apnea treatment push", "summary": "", "url": "https://news.google.com/rss/articles/CBMiowFBVV95cUxQbVFhQl9pa1M0YVNOLUZmUFFOWjhFc2Z6dU8tVG9fTGVkR3BJb0U5ZXBPYkhSSkFGMUdicUQ3bzFpdzludF9MZkNEZlVxd0NuSXFjSWJxcUR0dmJ6OU8zQmVwTGJTZk95TEJhc0VMRGwxNGYwbHdjbVVva3pTaVd6MVNBSTlsb2NndlJUb1ZXU3dqcFNqc3k1S2NSeE5wMGFuS0pF?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah Showcases Commercial Progress of Genio System in the United States", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxNSXZvSjhseUJlUU1kN0d4eWdUVWZmc0RfaDZOd0xQTlRCU1JtWGpjb0dJMVQwYm52THpwRmF5V1ZGcGlVQ0ZIaDdUcXhQSmJLV05UbVRkYk40aFpQMlFZWExDeElGdjJtdk9jbHVQUGZGcDh3UnpOa3ZXLW9ic3I4Q0NxWklLaUhjQllOaHpjNkhuR1Y5em93MXJkVVJhUGpyYXl3NUNSMjFrMHlCenlTbGpOMUlVY196THZtc1NIYm4xdTlsNDJnLVRwRE0?oc=5", "source_name": "Id\u00e9al Investisseur", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah Q1 Earnings Call Highlights", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNVEdad3FTOG1tWG5XcTZJR09fS0htZkp3anR1SHVQMzJRWDRXMmJVUzNDV0d5aGN2enprNENXYnRZdkI3cFVDMnF3bGpITnBXSzNNYmZHWllPbzVQeVhqYkFITHBSYm12RXBOaV9HaWZhamRfbVUtaTlvU2c4UDJVMmNzc19mNmFDNGs3Wjg5QWs0OWhVWFZnbHJrQQ?oc=5", "source_name": "TradingView", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah SA (NYXH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOOWJ5NEFKS3o0ZzR2TC1MU2RpSDBDbnBzd3N1UV9sRjV0SnVKaVBjNlExUU5EeEUwNUZWRkcwZXNGSmpmRktxM3J5b0dBb21xeVhSR2g0bEdtU2U2UmR6MDhjWEQ1MmV5QllqVHVqNjhqczVWRHB6bDZ1dzlCZlRVQ1BhWkRqQmYzWk8xYklDUjM0SjRN?oc=5", "source_name": "Market source", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah SA (NYXH) Reports Q4 Loss, Misses Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPcENvTjhHOUwxWEkxN3RnaC1SRWJKbl8zcVVSSnhZSmRDVTN2RzdSc2M0X0IxdVU4ZUVzQ2xIcHNBMzhQa3JUNEt0ZEkzSHVseGpFdTRQNHpnNmNRU3ZkRmNmRGxoTU1ad2o0MHpZdnJwUHFRT0Zyd3pKa0F4VWRmalNva3dpVnJxTGVnUXVXVTFMNmxK?oc=5", "source_name": "Market source", "published_at": "2026-03-19T07:00:00+00:00", "published_display": "19 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah Shares Rise on First U.S. Commercial Use of Genio System", "summary": "", "url": "https://news.google.com/rss/articles/CBMifEFVX3lxTFBvTGliVENUZXpqSTBqSUtkLW1Cc1lVNWZMMWctdUhNQ1FDZzEzalhjb0QtY1p2TnNsZE1Hblh4ZVB5VzNESjZsalFnZk5KNktaRXJWMlBKcGRJZWRTNFlnRnZtWWJvb3g0THNra2o1c3c2S0VFUVFWdk9zWEc?oc=5", "source_name": "Market source", "published_at": "2025-10-07T07:00:00+00:00", "published_display": "07 Oct 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nyxoah gets FDA clearance for sleep apnea device Genio", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxQczV4QmdHZHdQV2w0cVdQRFVCeG1QYzBidDM3YVZoak5jZ29abTR0Y19ObF9yYUEwbnZEVkQ4aHBET2U3Q2E4ZThEdk1XbW5yNVRVdElURkRpdjFGMGpLSmVydy1hLWNkam5XZXVPT0VwaVZacnBJV2N5MUtxN0lTUnlWZ050RExoSm5TUlltMA?oc=5", "source_name": "MobiHealthNews", "published_at": "2025-08-12T07:00:00+00:00", "published_display": "12 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "NYXOAH S A (NYXH) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE5xT3BjbjYtTThOSzhiNjE2aS1TWk1FNE5fZmFjay1oLWt3bnBQMFMzaU1QUTlKLU1fUHNXZE5lMVN6bzI2OTZFek5Kb2MxQQ?oc=5", "source_name": "Stock Titan", "published_at": "2021-06-29T17:02:00+00:00", "published_display": "29 Jun 2021 17:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 81, "total_relevant": 49, "sentiment_summary": {"positive": 13, "negative": 10, "neutral": 26, "score": 53, "total": 49, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 76, "events": [{"event": "general", "label": "Market update", "weight": 12.1, "count": 22}, {"event": "earnings", "label": "Earnings", "weight": 7.7, "count": 14}, {"event": "analyst", "label": "Analyst action", "weight": 3.3, "count": 6}, {"event": "deals", "label": "Deals and strategy", "weight": 1.65, "count": 3}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.1, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}], "positive_events": 13, "negative_events": 10}, "market_context": {"has_market_context": true, "latest_close": 1.71, "latest_week": "2026-07-10", "one_week_move": -0.6, "four_week_move": 23.0, "twelve_week_move": -47.5, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.83586, "market_dynamics_buy_signal": false, "relative_strength": -67.406748, "fair_value_gap": -76.1, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "undecided", "expectation_probability": 46.8832, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.6% over one week, +23.0% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 50, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 15}, {"label": "TradingView", "count": 5}, {"label": "Market source", "count": 5}, {"label": "Id\u00e9al Investisseur", "count": 4}, {"label": "Moomoo", "count": 3}, {"label": "GlobeNewswire", "count": 3}, {"label": "Investing.com", "count": 2}, {"label": "Investing.com Nigeria", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 49}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 22}, {"label": "Earnings", "count": 14}, {"label": "Analyst action", "count": 6}, {"label": "Deals and strategy", "count": 3}, {"label": "Balance sheet", "count": 2}, {"label": "Regulatory and legal", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "53/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "76/100 classification confidence."}, {"label": "Company focus", "value": "49", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-0.6% over one week, +23.0% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Price to sales forward of Nyxoah SA \u2013 SWB:5YI"}], "updated_at": "2026-07-16T00:21:34.435341+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}